As hK1 specific amidase activity in those studies was reduced incomparison to that of normal controls, we suggest that urinary hK1-specific amidaseactivity and, consequently, renal KKS activity, might also be reduced in the studiedgroup of CAD patients. This evidence concerns the gene HK1 and coronary artery disorder.